Literature DB >> 19278366

A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies.

Jaroslav A Hubacek1, Jan Pitha, Vera Adamkova, Vera Lanska, Rudolf Poledne.   

Abstract

BACKGROUND: Recently, the role of the FTO (fat mass and obesity associated) gene in obesity development was described in Western European, but not in Oceanic, cohorts. The objective of this study was to test the hypothesis that the FTO single nucleotide polymorphism (SNP) is associated with body mass index (BMI) in the Slavic population and to analyze if there could be sex-specific effects of the SNP on BMI, waist-to-hip ratio (WHR), and lipid parameters.
METHODS: We analyzed three large population-based samples comprising the post-MONICA study (1191 males, 1368 females) and the 3PMFs study (908 females).
RESULTS: FTO rs17817449 SNP was related to BMI in males (p=0.014). In the females from both the post-MONICA and the 3PMFs study, FTO had no effect on BMI. Sub-analysis of females from the 3PMFs study demonstrated that FTO had an effect on BMI in postmenopausal females (p=0.035) but not in premenopausal females (follicle-stimulating hormone <40 U/L was used as marker of premenopausal status). WHR and lipid parameters were not associated with FTO in any of the analyzed groups.
CONCLUSIONS: These results suggest that the effect of FTO SNP rs17817449 may be, in some populations at least, restricted to males and postmenopausal females.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278366     DOI: 10.1515/CCLM.2009.109

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

1.  FTO genotype and adiposity in children: physical activity levels influence the effect of the risk genotype in adolescent males.

Authors:  Robert A Scott; Mark E S Bailey; Colin N Moran; Richard H Wilson; Noriyuki Fuku; Masashi Tanaka; Athanasios Tsiokanos; Athanasios Z Jamurtas; Evangelia Grammatikaki; George Moschonis; Yannis Manios; Yannis P Pitsiladis
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

2.  Lack of association between a new tag SNP in the FTO gene and BMI in Czech-Slavonic population.

Authors:  Dana Dlouha; Vera Adamkova; Vera Lanska; Jaroslav A Hubacek
Journal:  Eur J Hum Genet       Date:  2010-07-28       Impact factor: 4.246

3.  Combined effects of FTO rs9939609 and MC4R rs17782313 on obesity and BMI in Chinese Han populations.

Authors:  Wei Huang; Yanlei Sun; Jiazhong Sun
Journal:  Endocrine       Date:  2010-11-10       Impact factor: 3.633

4.  The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population.

Authors:  Jaroslav A Hubacek; Ondrej Viklicky; Dana Dlouha; Silvie Bloudickova; Ruzena Kubinova; Anne Peasey; Hynek Pikhart; Vera Adamkova; Irena Brabcova; Eva Pokorna; Martin Bobak
Journal:  Nephrol Dial Transplant       Date:  2011-07-25       Impact factor: 5.992

5.  FTO variant, energy intake, physical activity and basal metabolic rate in Caucasians. The HAPIEE study.

Authors:  J A Hubáček; H Pikhart; A Peasey; R Kubínová; M Bobák
Journal:  Physiol Res       Date:  2010-10-15       Impact factor: 1.881

6.  The role of connexin 37 polymorphism in spontaneous abortion.

Authors:  M Kníže; J Piťha; J A Hubacek; T Fait
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

7.  Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.

Authors:  Xueqin Song; Lijuan Pang; Yufang Feng; Xiaoduo Fan; Xue Li; Wei Zhang; Jinsong Gao; Jianjiang Zhang; Katlyn Nemani; Hua Zhang; Luxian Lv
Journal:  Behav Brain Funct       Date:  2014-10-02       Impact factor: 3.759

8.  A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.

Authors:  Chris Church; Sheena Lee; Eleanor A L Bagg; James S McTaggart; Robert Deacon; Thomas Gerken; Angela Lee; Lee Moir; Jasmin Mecinović; Mohamed M Quwailid; Christopher J Schofield; Frances M Ashcroft; Roger D Cox
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

9.  CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects.

Authors:  J A Hubacek; L Dusek; O Majek; V Adamek; T Cervinkova; D Dlouha; J Pavel; V Adamkova
Journal:  Physiol Res       Date:  2021-03-17       Impact factor: 1.881

Review 10.  Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health.

Authors:  Iuliia Pavlovska; Anna Polcrova; Jeffrey I Mechanick; Jan Brož; Maria M Infante-Garcia; Ramfis Nieto-Martínez; Geraldo A Maranhao Neto; Sarka Kunzova; Maria Skladana; Jan S Novotny; Hynek Pikhart; Jana Urbanová; Gorazd B Stokin; Jose R Medina-Inojosa; Robert Vysoky; Juan P González-Rivas
Journal:  Nutrients       Date:  2021-07-08       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.